F8 and Renal insufficiency: Serelaxin, the recombinant form of human relaxin, was shown to be safe in patients with acute heart failure and mild-to-moderate renal insufficiency in the pre-RELAX-AHF, RELAX-AHF and RELAX-AHF2 trials [9].